Featured in this issue of the Visante Insider:

  • What You Need to Know From Last Week’s 340B Coalition Conference
  • Drug Diversion Software Doesn’t Run By Itself
  • Round and Round We Go: Revised Audit Protocols for Medicare Plans
  • PBMs Lower Drug Benefit Costs by $654 Billion
  • Wrap up – Compounding Sterile Drugs & Patient Safety
  • Visante Announces David Kvancz as New SVP, Strategic Client Relationships

Share this on Twitter: